1. Introduction {#sec1}
===============

Cancer rates are increasing globally. According to the World Health Organization (WHO) statistics, there were about 12.7 million cancer cases in 2008, and this number is expected to increase to 21 million by 2030. Cancer is the leading cause of death worldwide, accounting for 7.6 million deaths (around 13% of all deaths) in 2008. Pain is a common and burdensome symptom associated with cancer and its treatment \[[@B1], [@B2]\]. Most of cancer patients suffered pain due to the cancer itself (the tumor pressed on bones, nerves, or other organs), the treatment, or the tests done to diagnose cancer. It was said that 75%--90% cancer patients experienced pain during their illness and up to 50% of cancer pain is undertreated. It was reported that one quarter of the patients had newly diagnosed malignancies, one third of the patients are undergoing treatment, and three quarters of the patients with advanced disease experienced pain \[[@B3]\]. For those patients with metastasis to the other places, pain is especially prevalent. And it was reported that up to 80% of the cancer patients who have bone metastasis experienced pain \[[@B3]\].

Pain management is important in oncologic care and essential for maximizing patient outcomes \[[@B2], [@B4]\]. Mounting evidence showed that unrelieved pain significantly comprised overall quality of life and effective pain control was associated with survival \[[@B2], [@B4]\]. Health care practitioners depend heavily on opioid therapies for cancer pain. Although this therapy is very effective, it is with a lot of side effects, such as constipation, urinary retention, nausea, sedation, respiratory depression, myoclonus, delirium, sexual dysfunction, and hyperalgesia \[[@B5]\], so Complementary and Alternative Medicine (CAM), which is noninvasive and generally considered to be relatively free of toxicity, is used as an adjunct therapy with standard pain management techniques \[[@B6]\]. The earliest systematic review which included 18 trials showed that hypnosis, imagery, support groups, acupuncture, and healing touch were promising, particularly in the short term, but none can be recommended because of a paucity of rigorous trials \[[@B7]\]. And another review showed that approaches such as acupuncture, massage therapy, mind-body interventions, and music therapy could effectively reduce pain and enhance quality of life \[[@B6]\].

Now with the more and more published systematic reviews of CAM on adult cancer pain, it is necessary to use the methods of overview of systematic review to summarize the available evidence, appraise the evidence level, and give suggestions to future research and practice.

2. Methods {#sec2}
==========

2.1. Inclusion and Exclusion Criteria {#sec2.1}
-------------------------------------

Only systematic reviews or meta-analyses of CAM on adult cancer pain were included. Patients were diagnosed with cancer, regardless of cancer types. The interventions were CAM or CAM in combination with conventional cancer treatments. Here, we used the definitions by the WHO: "A comprehensive term used to refer to both traditional medical systems such as traditional Chinese medicine, Indian ayurverda, Arabic unani medicine, and to various forms of indigenous medicine" \[[@B8]\]. The treatments include psychological and self-help therapies, physical therapies (aromatherapy, acupuncture, massage, reflexology, and shiatsu), and unconventional medicine or drugs (homeopathy, herbal medicine, Essiac, and Bach flower remedies) \[[@B7]\]. If there were several systematic reviews that evaluated the same interventions on adult cancer pain, we included the one that included most primary studies.

2.2. Data Source and Study Selection {#sec2.2}
------------------------------------

We searched the Cochrane Library, PubMed, Embase, and ISI Web of Knowledge using the search term (Alternative medicine OR Homeopathy OR Acupuncture OR Reflexology OR Mind-body medicine OR Hypnosis OR Imagery OR Relaxation techniques OR Support groups OR Creative outlets OR music OR Biologic-based therapies OR Dietary supplements OR herbal OR nonherbal OR Manipulative and body-based methods OR Massage OR aromatherapy OR Magnet OR laser therapy OR Energy therapies OR Healing touch OR Reiki OR Complementary medicine OR Complementary Therapies OR Complementary Therapy OR Essiac OR traditional medicine OR shiatsu OR Ayurveda OR Phytotherapy) AND (cancers OR cancer OR neoplasm OR neoplasms OR tumor OR tumors OR adenocarcinoma) AND (pain OR pains) AND (meta-analysis OR meta-analyses OR systematic reviews OR systematic review) as title, abstract, or keyword. If possible, the medical heading terms such as MESH and EMTREE words were used. The reference lists of included systematic reviews were checked. All searches were conducted at 31 May, 2013, and updated at 31 August, 2013, and 17 February, 2014. There were not any restrictions in language, publication date, or publication type.

Two authors (Yanju Bao & Xiangying Kong) independently selected studies according to the inclusion criteria, and differences were resolved by a third reviewer (Baojin Hua).

2.3. Data Collection and Analysis {#sec2.3}
---------------------------------

We used "assessment of multiple systematic reviews" (AMSTAR) \[[@B9]\] to assess the methodological quality of systematic reviews, as studies showed that it has satisfactory interobserver agreement, reliability, and construct validity \[[@B10], [@B11]\]. This checklist contains 11 items: "a priori" design, duplicate study selection and data extraction, comprehensive literature search, the status of publication used as an inclusion criterion, a list of studies (included and excluded), the characteristics of the included studies, assessing and documenting the scientific quality, using the scientific quality appropriately in formulating conclusions, appropriate methods to combine the findings, assessing the likelihood of publication bias, and the conflict of interest. This checklist could not give a total score for the methodological quality, so we adopted the revision version \[[@B12]\]: Revised Assessment of Multiple Systematic Reviews (R-AMSTAR). This R-AMSTAR did not destroy the content and construct validity of AMSTAR \[[@B12]\]. According to this checklist, 44 is the maximum value. However, for item 2 in R-AMSTAR, it focuses on data extracting, and it seemed to ignore study selection. As we know, efforts to enhance objectivity and avoid mistakes in study selection are important \[[@B13]\]. Thus, we added item 2.1 (duplicate study selection) according to item 2 in R-AMSTER. So the total score for R-AMSTER was 48. And we defined the systematic review as of high quality (the score \>36), moderate quality (the score \>24), low quality (the score \>12), and very low quality (the score ≦12).

For the evaluation of the evidence levels for the outcomes, we used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach which specifies four levels of quality: high, moderate, low, and very low quality evidence \[[@B14]\]. Two investigators (Liping Yang & Rui Liu) extracted data from included studies; differences were resolved by a third reviewer (Baojin Hua). The data extraction form summarized key characteristics of systematic reviews, including information on participants, interventions, outcomes, author\'s conclusions, and items about quality.

3. Results {#sec3}
==========

3.1. Search Results {#sec3.1}
-------------------

We found 1318 citations by searching medical databases (Cochrane library: 531, Pubmed: 237, Embase: 328, ISI web of knowledge: 222) and 42 citations by reference tracking. After screening titles and abstracts, we excluded duplications (236 citations), studies that were not about cancer (293 citations) or CAM (351 citations) and that were not systematic reviews (301 citations). We also excluded studies that were not about pain (75 citations) or cancer (69 citations) based on screening the full text. Finally, we included 35 papers \[[@B7], [@B15]--[@B48]\] for this overview, but we only reviewed 27 papers \[[@B19]--[@B21], [@B23]--[@B34], [@B36]--[@B40], [@B42]--[@B48]\] in our paper, as some of them were overlapped.

3.2. Characteristics of Included Systematic Reviews {#sec3.2}
---------------------------------------------------

One systematic review \[[@B7]\] was about all CAM interventions; it focused on acupuncture, music, herbal supplement/Ai-TongPing, massage, and healing touch. The other 34 systematic reviews were about psychosocial interventions \[[@B15], [@B16], [@B22], [@B38], [@B42], [@B44], [@B45]\], massage therapy \[[@B17], [@B21], [@B24], [@B33], [@B46]\], acupuncture \[[@B18], [@B35], [@B36], [@B41], [@B43]\], reflexology \[[@B23], [@B30], [@B32]\], Chinese herbal medicine \[[@B20], [@B40], [@B48]\], music therapy \[[@B31], [@B39]\], transcutaneous electric nerve stimulation \[[@B37]\], cupping \[[@B34]\], cannabis \[[@B27]\], lycopene \[[@B25]\],*Viscum album* L (European Mistletoe) \[[@B29]\], Reiki \[[@B28]\], homeopathic therapy (Traumeel) \[[@B19]\], creative arts therapies \[[@B47]\], and internal qigong \[[@B26]\].

3.3. Quality of Included Systematic Reviews {#sec3.3}
-------------------------------------------

The total score for all systematic reviews ranges from 20 to 34 and all were of low or moderate quality. Of these systematic reviews, 23 \[[@B17], [@B18], [@B21], [@B22], [@B26]--[@B28], [@B30]--[@B33], [@B35]--[@B40], [@B42], [@B44]--[@B48]\] were of moderate quality and twelve \[[@B7], [@B15], [@B16], [@B19], [@B20], [@B23]--[@B25], [@B29], [@B34], [@B41], [@B43]\] were of low quality.

Six systematic reviews \[[@B7], [@B17], [@B31], [@B35], [@B37], [@B45]\] have "a priori" design, four systematic reviews \[[@B26], [@B31], [@B36], [@B39]\] conducted duplicate data extraction, six systematic reviews \[[@B17], [@B22], [@B38], [@B40], [@B43], [@B45]\] conducted duplicate study selection, 25 systematic reviews \[[@B7], [@B15]--[@B18], [@B21], [@B23]--[@B26], [@B29]--[@B35], [@B37], [@B40], [@B42]--[@B47]\] have comprehensive literature search, all systematic reviews provided a list of studies (included and excluded), 24 systematic reviews \[[@B15]--[@B17], [@B19]--[@B21], [@B24], [@B26]--[@B28], [@B30]--[@B32], [@B35]--[@B37], [@B39], [@B40], [@B42]--[@B46], [@B48]\] provided the characteristics of the included studies, and five systematic reviews \[[@B27], [@B30], [@B31], [@B33], [@B39]\] assessed and documented the scientific quality of the included studies. The other details of quality were presented in [Table 1](#tab1){ref-type="table"}.

3.4. Summary of Findings {#sec3.4}
------------------------

Five systematic reviews \[[@B17], [@B21], [@B24], [@B33], [@B46]\] were about massage on cancer pain. Two systematic reviews \[[@B17], [@B21]\] used the same included studies, and two systematic reviews \[[@B24], [@B33]\] included different studies, although they both conducted search after 2006. And the fifth \[[@B46]\] was a meta-analysis about breast cancer. So we reviewed four of them \[[@B21], [@B24], [@B33], [@B46]\]. Three of them \[[@B21], [@B24], [@B33]\] gave a conclusion that massage may have a beneficial effect on cancer pain without pooling the data. However, they included different primary studies: four randomized controlled trials (RCTs) \[[@B49]--[@B52]\] for systematic review by Wilkinson et al. \[[@B21]\], five RCTs \[[@B21], [@B50], [@B53]--[@B55]\] for systematic review by Ernst et al. \[[@B24]\], and three RCTs \[[@B51], [@B53], [@B56]\] for systematic review by Falkensteiner et al. \[[@B33]\]. The fifth systematic review \[[@B46]\] pooled the data and showed no benefits of massage on pain for breast cancer patients based on four different RCTs \[[@B57]--[@B60]\]. So based on available evidence, we could see that the conclusions for the benefits of massage on cancer pain were conflicted.

Four systematic reviews \[[@B18], [@B35], [@B36], [@B43]\] assessed the effects of acupuncture on cancer pain. The latest one \[[@B43]\] reviewed all available evidence of acupuncture plus drug therapy versus drug therapy on cancer pain and showed that acupuncture plus drug therapy might be better than drug therapy. Among the remaining three systematic reviews, the one by Choi et al. \[[@B36]\] was the most comprehensive one. This systematic review showed that acupuncture did not generate better effects on pain relief than drug therapy and sham acupuncture and that acupuncture plus drug therapy was better in managing cancer pain than drug therapy. In a word, available evidence showed that acupuncture plus drug therapy might be better than drug therapy in managing cancer pain.

Three systematic reviews \[[@B15], [@B16], [@B38]\] assessed the effects of psychosocial interventions on cancer pain and the latest \[[@B38]\] was the most comprehensive one. This systematic review \[[@B38]\] included 37 RCTs and showed that psychosocial interventions had medium-size effects on cancer pain severity and interference. Two systematic reviews \[[@B42], [@B45]\] assessed the effects of psychosocial interventions on pain for breast cancer patients. Both showed benefits on cancer pain, although they included different studies. Two systematic reviews \[[@B22], [@B44]\] assessed the effects of educational interventions on cancer pain, of them one \[[@B44]\] is the more comprehensive which showed that educational interventions can result in modest benefits in the management of cancer pain. Totally, psychoeducational interventions including psychosocial and educational interventions could be helpful for managing cancer pain.

Three systematic reviews \[[@B23], [@B30], [@B32]\] assessed the effects of reflexology on cancer pain. Two systematic reviews \[[@B23], [@B32]\] included one crossover RCT about breast and lung cancer, and the other systematic review \[[@B30]\] included two N-RCTs about breast cancer. Although these three systematic reviews included few studies, they all showed that reflexology may be beneficial in reducing cancer pain.

Three systematic reviews evaluated the effects of Chinese herbal medicine on cancer pain \[[@B20], [@B40], [@B48]\]. Systematic review by Xu et al. \[[@B20]\] showed that Chinese herbal medicine may be useful for managing cancer pain. The meta-analysis by Wang et al. \[[@B48]\] showed that Chinese herbal medicine plus conventional treatment increased the pain-relief rate as compared with the conventional treatment for pain secondary to bone metastases, and the meta-analysis by Bao et al. \[[@B40]\] showed that Chinese medicine, compound kushen injection, was associated with improving pain relief for bone cancer pain. Totally, we could see that Chinese herbal medicine may be beneficial in managing cancer pain.

Two systematic reviews \[[@B31], [@B39]\] evaluated the effects of music interventions on cancer pain. However, their included studies were different, as they were conducted at different times and/or by authors in different countries. These two systematic reviews showed that music interventions were associated with a moderate pain-reducing effect for cancer patients.

For other CAM interventions, lycopene \[[@B25]\], qigong \[[@B26]\], cupping \[[@B34]\], cannabis \[[@B27]\], Reiki \[[@B28]\], homeopathic therapy (Traumeel) \[[@B19]\], transcutaneous electric nerve stimulation (TENS) \[[@B37]\], creative arts therapies \[[@B47]\], and*Viscum album* L \[[@B29]\], there was only one systematic review for each. Studies showed that lycopene, qigong, cupping, cannabis, homeopathy (Traumeel), creative arts therapies, and Reiki might have beneficial effects on cancer pain. For TENS and*Viscum album* L, evidence was less consistently.

3.5. Evidence Level {#sec3.5}
-------------------

Among the 27 systematic reviews we summarized, 18 systematic reviews \[[@B19]--[@B21], [@B23], [@B25], [@B27], [@B28], [@B31]--[@B34], [@B36], [@B37], [@B39], [@B40], [@B45], [@B46], [@B48]\] have small sample size, there were high heterogeneity in eight systematic reviews \[[@B19], [@B29], [@B31], [@B36], [@B39], [@B43], [@B46], [@B47]\], the risks of bias of 22 systematic reviews \[[@B19]--[@B21], [@B23]--[@B25], [@B27]--[@B29], [@B32], [@B34], [@B36]--[@B38], [@B40], [@B42]--[@B48]\] were high, and two systematic reviews \[[@B26], [@B30]\] included observational studies. So based on GRADE approach, the evidence levels for music, reflexology, lycopene, qigong, cupping, cannabis, Reiki, TENS, Chinese herbal medicine, homeopathy (Traumeel), creative arts therapies, and*Viscum album* L were low. For acupuncture, evidence was low for acupuncture or acupuncture + drug therapy (versus drug therapy) and very low for acupuncture (versus sham acupuncture). For massage therapy and psychoeducational interventions (psychosocial and educational interventions), the number of included studies was different, so the evidence level was low or moderate.

4. Discussion {#sec4}
=============

4.1. Summary of Finding {#sec4.1}
-----------------------

Based on available evidence, we could find that psychoeducational interventions, music interventions, acupuncture plus drug therapy, Chinese herbal medicine plus cancer therapy, compound kushen injection, reflexology, lycopene, TENS, qigong, cupping, cannabis, Reiki, homeopathy (Traumeel), and creative arts therapies might have beneficial effects on adult cancer pain. No benefits were found for acupuncture (versus drug therapy or shame acupuncture), and the results were inconsistent among studies for massage therapy, transcutaneous electric nerve stimulation (TENS), and*Viscum album* L plus cancer treatment. The methodological quality for primary studies was not very good and the evidence levels for these interventions were low or moderate, so firm conclusions could not be drawn. Based on all evidence we collected, we could not recommend any CAM interventions for adult cancer pain because of small sample size, high heterogeneity across studies, and high risk of bias for primary studies.

It was reported that the use of CAM among cancer patients is widespread and appears to be increasing \[[@B8]\]. Surveys on the use of CAM among cancer patients have been reported as high as 64% and as low as 7% \[[@B61]\]. For example, a survey on the use of CAM among patients with haematological cancers in 14 European countries showed that 36% of cancer patients in Europe have used one or more forms of CAM modalities \[[@B62]\]. Similar studies in New Zealand and Canada showed 42% and 43% prevalence rate of CAM use among cancer patients \[[@B63], [@B64]\].

Cancer patients were hoping to better control cancer and cancer-related pain, so they turned to CAM. Ernst \[[@B65]\] grouped the reasons given by patients for their use of CAM into push factors (negative) which pushes patients away from conventional medicine and pull factors (positive) which relates to the positive aspects of CAM. Study also showed that CAM might give cancer patients strength to go through the conventional therapies, relieve their symptoms, improve their quality of life \[[@B66], [@B67]\], and further increase the body\'s ability to fight off the disease \[[@B62]\].

Although more and more cancer patients turned to CAM to cure their disease, the evidence levels for the benefits of CAM on cancer pain were not satisfied. We could see from [Table 2](#tab2){ref-type="table"} that the evidence levels for all interventions were low or moderate. For most interventions, they were of low evidence level. Among these interventions, acupuncture plus drug therapy, Chinese herbal medicine, creative arts therapies, cannabis, cupping, lycopene, Reiki, qigong, music interventions, homeopathy (Traumeel), and reflexology might be beneficial in reducing cancer pain. Only two interventions (psychosocial intervention and massage therapy) from five systematic reviews were of moderate evidence level. However, definitive conclusions were not achieved for most of them due to the methodological problems and/or small sample size.

Where does the unsatisfied evidence level come from? According to 27 systematic reviews we summarized, small sample size, high heterogeneity across studies, and high risk of bias for primary studies were the reasons. Trials of complementary therapies often have relevant methodological weaknesses \[[@B68]\]. According to the systematic review by Garcia et al. \[[@B41]\], 33 of 41 RCTs about acupuncture for symptom management in cancer care were of high risk of bias. The earliest systematic review \[[@B7]\] of CAM in relieving cancer pain also found that the included RCTs were of high risk of bias. Studies have also found that insufficient sample size was common in CAM studies \[[@B69], [@B70]\]. For heterogeneity, that might be due to different administrative ways of CAM. So in the future, when designing the RCTs that compared CAM with placebo or other interventions, a rational sample size calculation should be well done. Meanwhile, the key methodological aspects, such as methods of randomization, concealed allocation, and blinding, should be well conducted and reported.

4.2. Strength and Limitations {#sec4.2}
-----------------------------

Our overview was the first one which systematically reviewed available systematic reviews of CAM on adult cancer pain. We searched medical databases and hand-searched reference lists and used GRADE to evaluate the evidence levels for each kind of CAM. However, our systematic overview had its own limitations. First, we only included systematic reviews and this means that we did not include primary studies that evaluated CAM for adult cancer pain. For reflexology, the systematic reviews in our overview showed that reflexology might be beneficial on adult cancer pain, but a recent study showed no differences among reflexology, lay foot manipulation, and conventional care \[[@B71]\]. For yoga, there was not a systematic review that evaluated its effect on cancer pain. A recent RCT \[[@B72]\] which compared yoga with wait-list control showed that the yoga group reduced daily joint pain for breast cancer patients. Second, the critical problem for these primary RCTs of CAM on adult cancer pain was of low quality and of small sample size. For example, all included RCTs in the systematic review by Choi et al. \[[@B36]\] were associated with high risk of bias. Meanwhile, few studies were included in systematic reviews. For example, only one crossover RCT and two N-RCTs were about reflexology, two RCTs were about Reiki, and one RCT was about cupping.

4.3. Implications for Future Research and Practice {#sec4.3}
--------------------------------------------------

Due to high risk of bias for primary studies, the evidence levels for each CAM were low or moderate. So in the future, in order to prescribe CAM, the health care professionals should be more careful. Based on available evidence, we could not recommend any CAM interventions for cancer pain due to small sample size, high heterogeneity across studies, and high risk of bias for primary studies.

The methodological quality for primary studies was low and their sample size was small, so in the future large and well-designed RCTs should be conducted to confirm the conclusions of available systematic reviews.

5. Conclusions {#sec5}
==============

Based on available evidence, psychoeducational interventions, music interventions, acupuncture plus drug therapy, Chinese herbal medicine plus cancer therapy, compound kushen injection, reflexology, lycopene, TENS, qigong, cupping, cannabis, Reiki, homeopathy (Traumeel), and creative arts therapies might have beneficial effects on cancer pain. No benefits were found for acupuncture (versus drug therapy or shame acupuncture), and the results were inconsistent among studies for massage therapy, transcutaneous electric nerve stimulation (TENS), and*Viscum album* L plus cancer treatment. The methodological quality for primary studies was not high and the evidence levels for these interventions were low or moderate, so firm conclusions could not be drawn. Based on all evidence we collected, we could not recommend any CAM interventions for adult cancer pain because of small sample size, high heterogeneity across studies, and high risk of bias for primary studies.

This work was partially supported by the National Natural Science Foundation of China (no. 81273718 and no. 81302961). Yanju Bao and Liping Yang are the cofirst authors.

Conflict of Interests
=====================

The authors declare that they have no conflict of interests, as the funder did not play any role in study design or conduct.

###### 

Quality of all included systematic reviews.

  Study                                   1     2     2.1   3       4    5      6     7      8    9     10    11   Total   Quality
  --------------------------------------- ----- ----- ----- ------- ---- ------ ----- ------ ---- ----- ----- ---- ------- ----------
  Bardia et al. 2006 \[[@B7]\]            ABC   A     0     ABCD    0    AD     AC    AB     A    0     0     B    24      Low
  Bradt et al. 2011 \[[@B31]\]            ABC   ABC   0     ABCDE   0    ABCD   ABC   ABCD   A    C     A     AB   32      Moderate
  Choi et al. 2012 \[[@B36]\]             BC    ABC   0     ABC     BD   AD     ABC   AB     A    BCD   0     AB   30      Moderate
  Devine and Westlake 1995 \[[@B15]\]     BC    0     0     ABCD    0    AD     ABC   AB     A    A     0     A    23      Low
  Devine 2003 \[[@B16]\]                  BC    0     0     ABCD    0    AD     ABC   AB     A    A     0     A    23      Low
  Ernst 2009 \[[@B23]\]                   C     0     0     ABCD    0    AD     AC    AB     A    0     0     B    21      Low
  Ernst 2009 \[[@B24]\]                   BC    0     0     ABCD    AD   AD     ABC   AB     A    0     0     0    24      Low
  Ernst et al. 2011 \[[@B32]\]            BC    0     0     ABCD    B    AD     ABC   AB     A    0     0     AB   25      Moderate
  Falkensteiner et al. 2011 \[[@B33]\]    BC    0     A     ABDE    B    ABCD   AC    ABCD   A    0     0     0    27      Moderate
  Fellowes et al. 2004 \[[@B17]\]         ABC   0     ABC   ABCDE   AD   ABCD   ABC   AB     0    0     0     B    31      Moderate
  Haseen et al. 2009 \[[@B25]\]           BC    A     A     ABCD    0    AD     AC    AB     A    0     0     B    24      Low
  Hurlow et al. 2012 \[[@B37]\]           ABC   A     0     ABCD    0    ABCD   ABC   AB     A    C     0     AB   27      Moderate
  Garcia et al. 2013 \[[@B41]\]           BC    A     A     ABC     B    AD     0     AB     0    0     0     B    22      Low
  Kienle and Kiene 2010 \[[@B29]\]        BC    0     0     ABCD    0    AD     AC    AB     A    0     0     A    22      Low
  Kim et al. 2010 \[[@B30]\]              BC    0     0     ABCD    D    AD     ABC   ABCD   A    0     0     AB   27      Moderate
  Lee et al. 2005 \[[@B18]\]              BC    A     0     ABCD    D    ABCD   AC    AB     A    0     0     A    26      Moderate
  Lee et al. 2009 \[[@B26]\]              BC    ABC   0     ABCD    0    ABCD   ABC   AB     A    0     0     A    27      Moderate
  Lee et al. 2011 \[[@B34]\]              BC    A     0     ABCD    D    AD     AC    AB     A    0     0     A    24      Low
  Martín-Sánchez et al. 2009 \[[@B27]\]   BC    0     0     ABC     AD   AD     ABC   ABCD   0    C     AB    AB   29      Moderate
  Paley et al. 2011 \[[@B35]\]            ABC   0     0     ABCD    AD   ABCD   ABC   AB     A    BCD   AB    B    31      Moderate
  Gorin et al. 2012 \[[@B38]\]            BC    0     ABC   ABC     B    ABCD   0     0      0    BC    AB    B    27      Moderate
  Edwards et al. 2004 \[[@B45]\]          ABC   A     ABC   ABCD    B    ABCD   ABC   AB     AB   BCD   0     A    34      Moderate
  Johannsen et al. 2013 \[[@B42]\]        BC    0     AB    ABCD    B    AD     ABC   AB     AB   BCD   0     A    28      Moderate
  Bennett et al. 2009 \[[@B22]\]          BC    0     ABC   ABD     0    AD     A     AB     AB   BCD   0     A    26      Moderate
  Marie et al. 2013 \[[@B44]\]            BC    0     A     ABCD    B    AD     ABC   AB     AB   BCD   0     0    27      Moderate
  Vandervaart et al. 2009 \[[@B28]\]      BC    0     0     ABC     0    AD     ABC   AB     A    0     0     A    22      Moderate
  Wilkinson et al. 2008 \[[@B21]\]        BC    0     A     ABCDE   AD   ABCD   ABC   AB     A    0     0     B    28      Moderate
  Xu et al. 2007 \[[@B20]\]               B     0     0     ABC     0    AD     ABC   AB     A    0     0     0    20      Low
  Wang et al. 2013 \[[@B48]\]             BC    0     0     ABD     AC   AD     ABC   AB     A    BCD   ABC   A    28      Moderate
  Bao et al. 2013 \[[@B40]\]              BC    A     ABC   ABCD    0    AD     ABC   AB     A    BCD   AB    A    31      Moderate
  Zhang et al. 2012 \[[@B39]\]            BC    ABC   0     ABC     0    AD     ABC   ABCD   A    C     0     B    27      Moderate
  Pan et al. 2013 \[[@B46]\]              BC    0     0     ABCD    B    AD     ABC   AB     AB   BCD   0     B    27      Moderate
  Lian et al. 2013 \[[@B43]\]             BC    0     ABC   ABCD    0    AD     ABC   A      0    0     0     0    24      Low
  Milazzo et al. 2006 \[[@B19]\]          BC    0     0     ABC     0    AD     ABC   AB     A    0     0     B    22      Low
  Puetz et al. 2013 \[[@B47]\]            BC    0     0     ABCD    B    AD     0     AB     A    BCD   ABC   B    26      Moderate

###### 

Summary of finding for 27 included systematic reviews.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                                   Search time        Study (sample size)      Interventions                                      Comparison                        Main result    Recommendation   Evidence level
  --------------------------------------- ------------------ ------------------------ -------------------------------------------------- --------------------------------- -------------- ---------------- -----------------
  Bradt et al. 2011 \[[@B31]\]            September 2010     7 RCTs (391)             Music                                              Standard care                     Benefits       Yes              Low^1,2^

  Choi et al. 2012 \[[@B36]\]             April 2011         15 RCTs (1157)           Acupuncture                                        Drug                              No effect      No               Low^2,3^

  Acupuncture + drug                      Drug               Benefits                 Low^2,3^                                                                                                             

  Acupuncture                             Sham acupuncture   No effect                Verylow^1,2,3^                                                                                                       

  Lian et al. 2013 \[[@B43]\]             June 2010          6 RCTs (476)             Acupuncture + drug                                 Drug                              Benefits       No               Low^2,3^

  Ernst 2009 \[[@B23]\] and \             September 2010     1 RCT (23)               Reflexology                                        No treatment                      Benefits       No               Low^1,3^
  Ernst et al. 2011 \[[@B32]\]^*※*^                                                                                                                                                                        

  Ernst 2009 \[[@B24]\]                   November 2008      5 RCTs (781)             Massage                                            Control                           Benefits       No               Moderate^3^

  Falkensteiner et al. 2011 \[[@B33]\]    July 2010          3 RCTs, 2 N-RCT (1841)   Massage                                            Control                           Benefits       No               Moderate^1^

  Pan et al. 2013 \[[@B46]\]^§^           November 2012      4 RCTs                   Massage                                            Control                           No effect      No               Very low^1,2,3^

  Wilkinson et al. 2008 \[[@B21]\]        2006               4 RCTs (212)             Massage                                            Control                           Benefits       No               Low^1,3^

  Haseen et al. 2009 \[[@B25]\]^\#^       January 2009       1 RCT (54)               Lycopene                                           No treatment                      Benefits       No               Low^1,3^

  Hurlow et al. 2012 \[[@B37]\]           April 2008         3 RCTs (88)              TENS                                               Placebo                           Inconsistent   No               Low^1,3^

  Kienle and Kiene 2010 \[[@B29]\]        October 2009       5 RCTs (745)             *Viscum album* l + cancer treatment                Cancer treatment                  Inconsistent   No               Low^2,3^

  Kim et al. 2010 \[[@B30]\]^§^           July 2010          2 N-RCTs (58)            Reflexology                                        No treatment                      Benefits       No               Low^4^

  Lee et al. 2009 \[[@B26]\]^§^           February 2009      1 CCT (133)              Qigong                                             Control                           Benefits       No               Low^4^

  Lee et al. 2011 \[[@B34]\]              January 2009       1 RCT (60)               Cupping                                            Drug                              Benefits       No               Low^1,3^

  Martín-Sánchez et al. 2009 \[[@B27]\]   February 2008      5 RCTs (290)             Cannabis                                           Placebo                           Benefits       No               Low^1,3^

  Gorin et al. 2012 \[[@B38]\]            2010               37 RCTs (4199)           Psychosocial intervention                          Usual care                        Benefits       Yes              Moderate^3^

  Edwards et al. 2004 \[[@B45]\]^§^       June 2011          3 RCTs (279)             Psychosocial intervention                          Usual care                        Benefits       Yes              Low^1,3^

  Johannsen et al. 2013 \[[@B42]\]^§^     December 2012      26 trials (1786)         Psychosocial intervention                          Usual care                        Benefits       Yes              Moderate^3^

  Marie et al. 2013 \[[@B44]\]            May 2012           15 trials (1710)         Education                                          Usual care                        Benefits       Yes              Moderate^3^

  Vandervaart et al. 2009 \[[@B28]\]      December 2008      2 RCTs (40)              Reiki                                              Control                           Benefits       No               Low^1,3^

  Xu et al. 2007 \[[@B20]\]               2006               41 RCTs (2902)           Chinese herbal medicine + cancer therapy           Cancer therapy                    Benefits       No               Low^1,3^

  Wang et al. 2013 \[[@B48]\]             December 2012      16 RCTs (1008)           Chinese herbal medicine + conventional treatment   Conventional treatment            Benefits       No               Low^1,3^

  Bao et al. 2013 \[[@B40]\]              December 2012      7 RCTs (521)             Compound kushen injection                          Radiotherapy or bisphosphonates   Benefits       No               Low^1,3^

  Zhang et al. 2012 \[[@B39]\]            March 2011         7 RCTs (603)             Music intervention                                 Standard care                     Benefits       No               Low^1,2^

  Milazzo et al. 2006 \[[@B19]\]          2005               2 RCTs (57)              Homeopathy (Traumeel)                              No treatment/Placebo              Benefits       No               Low^1,3^

  Puetz et al. 2013 \[[@B47]\]            January 2012       18 trials (1237)         Creative arts therapies                            No treatment                      Benefits       No               Low^2,3^
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

TENS: Transcutaneous Electric Nerve Stimulation; RCT: randomized controlled trial; N-RCT: non-randomized controlled trial; CCT: clinical controlled trial; ^*※*^breast cancer and lung cancer; ^§^Breast cancer; ^\#^Prostate cancer; ^1^the total sample size was small; ^2^there was a high heterogeneity; ^3^the risk of bias was high; ^4^observational study.

[^1]: Academic Editor: Ke Ren
